Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) EBT Margin (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed EBT Margin for 13 consecutive years, with 227.86% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 22785.0% year-over-year to 227.86%, compared with a TTM value of 27.73% through Dec 2025, down 1796.0%, and an annual FY2025 reading of 2532.84%, up 254262.0% over the prior year.
  • EBT Margin was 227.86% for Q4 2025 at Tandem Diabetes Care, down from 10.11% in the prior quarter.
  • Across five years, EBT Margin topped out at 5.31% in Q4 2021 and bottomed at 227.86% in Q4 2025.
  • Average EBT Margin over 5 years is 25.97%, with a median of 11.75% recorded in 2024.
  • The sharpest move saw EBT Margin skyrocketed 5234bps in 2024, then crashed -22785bps in 2025.
  • Year by year, EBT Margin stood at 5.31% in 2021, then plummeted by -238bps to 7.33% in 2022, then crashed by -118bps to 15.93% in 2023, then surged by 100bps to 0.01% in 2024, then tumbled by -2385192bps to 227.86% in 2025.
  • Business Quant data shows EBT Margin for TNDM at 227.86% in Q4 2025, 10.11% in Q3 2025, and 23.98% in Q2 2025.